146 related articles for article (PubMed ID: 26116512)
1. Primary Central Nervous System (CNS) Lymphoma B Cell Receptors Recognize CNS Proteins.
Montesinos-Rongen M; Purschke FG; Brunn A; May C; Nordhoff E; Marcus K; Deckert M
J Immunol; 2015 Aug; 195(3):1312-9. PubMed ID: 26116512
[TBL] [Abstract][Full Text] [Related]
2. Comment on "Primary Central Nervous System (CNS) Lymphoma B Cell Receptors Recognize CNS Proteins".
Spies E; Fichtner M; Müller F; Krasemann S; Illerhaus G; Glatzel M; Binder M; Trepel M
J Immunol; 2015 Nov; 195(10):4549-50. PubMed ID: 26546683
[No Abstract] [Full Text] [Related]
3. The process of somatic hypermutation increases polyreactivity for central nervous system antigens in primary central nervous system lymphoma.
Montesinos-Rongen M; Terrao M; May C; Marcus K; Blümcke I; Hellmich M; Küppers R; Brunn A; Deckert M
Haematologica; 2021 Mar; 106(3):708-717. PubMed ID: 32193251
[TBL] [Abstract][Full Text] [Related]
4. Response to Comment on "Primary Central Nervous System (CNS) Lymphoma B Cell Receptors Recognize CNS Proteins".
Montesinos-Rongen M; Purschke F; Brunn A; Deckert M
J Immunol; 2015 Nov; 195(10):4550-1. PubMed ID: 26546684
[No Abstract] [Full Text] [Related]
5. Immunoglobulin repertoire of primary lymphomas of the central nervous system.
Montesinos-Rongen M; Purschke F; Küppers R; Deckert M
J Neuropathol Exp Neurol; 2014 Dec; 73(12):1116-25. PubMed ID: 25383641
[TBL] [Abstract][Full Text] [Related]
6. Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma.
Coupland SE; Loddenkemper C; Smith JR; Braziel RM; Charlotte F; Anagnostopoulos I; Stein H
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3957-64. PubMed ID: 16249468
[TBL] [Abstract][Full Text] [Related]
7. Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice.
Deckert M; Montesinos-Rongen M; Brunn A; Siebert R
Acta Neuropathol; 2014 Feb; 127(2):175-88. PubMed ID: 24240734
[TBL] [Abstract][Full Text] [Related]
8. M2 macrophage/microglial cells induce activation of Stat3 in primary central nervous system lymphoma.
Komohara Y; Horlad H; Ohnishi K; Ohta K; Makino K; Hondo H; Yamanaka R; Kajiwara K; Saito T; Kuratsu J; Takeya M
J Clin Exp Hematop; 2011; 51(2):93-9. PubMed ID: 22104307
[TBL] [Abstract][Full Text] [Related]
9. Self-antigen recognition by follicular lymphoma B-cell receptors.
Sachen KL; Strohman MJ; Singletary J; Alizadeh AA; Kattah NH; Lossos C; Mellins ED; Levy S; Levy R
Blood; 2012 Nov; 120(20):4182-90. PubMed ID: 23024238
[TBL] [Abstract][Full Text] [Related]
10. A genetic approach to idiotypic vaccination for B cell lymphoma.
Stevenson FK; Zhu D; King CA; Ashworth LJ; Kumar S; Thompsett A; Hawkins RE
Ann N Y Acad Sci; 1995 Nov; 772():212-26. PubMed ID: 8546396
[TBL] [Abstract][Full Text] [Related]
11. Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.
Grommes C; Pastore A; Palaskas N; Tang SS; Campos C; Schartz D; Codega P; Nichol D; Clark O; Hsieh WY; Rohle D; Rosenblum M; Viale A; Tabar VS; Brennan CW; Gavrilovic IT; Kaley TJ; Nolan CP; Omuro A; Pentsova E; Thomas AA; Tsyvkin E; Noy A; Palomba ML; Hamlin P; Sauter CS; Moskowitz CH; Wolfe J; Dogan A; Won M; Glass J; Peak S; Lallana EC; Hatzoglou V; Reiner AS; Gutin PH; Huse JT; Panageas KS; Graeber TG; Schultz N; DeAngelis LM; Mellinghoff IK
Cancer Discov; 2017 Sep; 7(9):1018-1029. PubMed ID: 28619981
[TBL] [Abstract][Full Text] [Related]
12. Molecular aspects of immunoglobulin expression by human B cell leukemias and lymphomas.
Gordon J
Adv Cancer Res; 1984; 41():71-154. PubMed ID: 6428177
[No Abstract] [Full Text] [Related]
13. Hyper-
Thurner L; Preuss KD; Bewarder M; Kemele M; Fadle N; Regitz E; Altmeyer S; Schormann C; Poeschel V; Ziepert M; Walter S; Roth P; Weller M; Szczepanowski M; Klapper W; Monoranu C; Rosenwald A; Möller P; Hartmann S; Hansmann ML; Mackensen A; Schäfer H; Schorb E; Illerhaus G; Buslei R; Bohle RM; Stilgenbauer S; Kim YJ; Pfreundschuh M
Blood; 2018 Dec; 132(26):2744-2753. PubMed ID: 30249786
[TBL] [Abstract][Full Text] [Related]
14. Mutations of CARD11 but not TNFAIP3 may activate the NF-kappaB pathway in primary CNS lymphoma.
Montesinos-Rongen M; Schmitz R; Brunn A; Gesk S; Richter J; Hong K; Wiestler OD; Siebert R; Küppers R; Deckert M
Acta Neuropathol; 2010 Oct; 120(4):529-35. PubMed ID: 20544211
[TBL] [Abstract][Full Text] [Related]
15. Genetic evidence implies that primary and relapsed tumors arise from common precursor cells in primary central nervous system lymphoma.
Hattori K; Sakata-Yanagimoto M; Kusakabe M; Nanmoku T; Suehara Y; Matsuoka R; Noguchi M; Yokoyama Y; Kato T; Kurita N; Nishikii H; Obara N; Takano S; Ishikawa E; Matsumura A; Muratani M; Hasegawa Y; Chiba S
Cancer Sci; 2019 Jan; 110(1):401-407. PubMed ID: 30353605
[TBL] [Abstract][Full Text] [Related]
16. Primary central nervous system lymphoma in Korea: comparison of B- and T-cell lymphomas.
Choi JS; Nam DH; Ko YH; Seo JW; Choi YL; Suh YL; Ree HJ
Am J Surg Pathol; 2003 Jul; 27(7):919-28. PubMed ID: 12826884
[TBL] [Abstract][Full Text] [Related]
17. AIDS primary central nervous system lymphoma: molecular analysis of the expressed VH genes and possible implications for lymphomagenesis.
Julien S; Radosavljevic M; Labouret N; Camilleri-Broet S; Davi F; Raphael M; Martin T; Pasquali JL
J Immunol; 1999 Feb; 162(3):1551-8. PubMed ID: 9973412
[TBL] [Abstract][Full Text] [Related]
18. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma.
Yushi Q; Li Z; Von Roemeling CA; Doeppler H; Marlow LA; Kim BY; Radisky DC; Storz P; Copland JA; Tun HW
Oncotarget; 2016 May; 7(22):32156-71. PubMed ID: 27050077
[TBL] [Abstract][Full Text] [Related]
20. The immune contexture of primary central nervous system diffuse large B cell lymphoma associates with patient survival and specific cell signaling.
Alame M; Cornillot E; Cacheux V; Rigau V; Costes-Martineau V; Lacheretz-Szablewski V; Colinge J
Theranostics; 2021; 11(8):3565-3579. PubMed ID: 33664848
[No Abstract] [Full Text] [Related]
[Next] [New Search]
